In Vitro Fertilization Market Research Report- Forecast To 2027

In Vitro Fertilization Market Share, Growth And Trends Analysis By Type (Intrauterine Insemination, Intracytoplasmic Sperm Injection, Ivf Using Donor Eggs), By Devices (Imaging Systems, Sperm Separation System, Ovum Aspiration Pump, Micromanipulator, Cryosystem) By Reagents (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media), By End Users (Clinical Research Institutes, Fertility Clinics, Hospitals) - Forecast to 2027

ID: MRFR/LS/1682-CR | October, 2018 | Region : Global

Market Overview


In-Vitro Fertilization (IVF) Market will witness an impressive CAGR of 10.50% in the forecast period and achieve a valuation of over USD 12,700 Mn as per the latest report published by Market Research Report. The plummeting natural fertility rates are estimated to create a promising scope for the IVF devices and consumables market in the coming period.


COVID-19 Analysis


The financial consequences of folding job losses and the housing market are estimated to develop the fertility clinic industry substantially. The shuttering of IVF clinics is also estimated to amplify waiting lists for couples trying to conceive this year. The surge in households' expenditure is expected to create severe restrictions on the development of the in vitro fertilization market share in the approaching period. Moreover, as fertility-related issues are not critical to an individual's health and well-being, especially in the current pandemic's scope, they are predicted to contribute to decelerated development in the IVF market growth.


Market Dynamics


Drivers


Robust Regulatory Frameworks


The existence of suitable regulatory frameworks has aided in the development of assisted reproduction technologies such as embryo culture media market are likely to gain quick acceptance in advanced economies. At the same time, their penetration remains relatively slower in developing countries.


High Average Conception Age


The average age of first-time mothers has multiplied radically in the global market. This inclination is estimated to improved contraceptive techniques and the mounting number of women choosing to delay the starting of a family.


Opportunities


Progressive Technology Availability


The intensification of infertility cases is contributing to the advancement of advanced technologies such as lensless imaging of the sperms, which is anticipated to usher in a new phase of growth in vitro fertilization market share in the coming years.


Surge in Fertility Medical Tourism


The low cost for superior healthcare amenities provided by doctors and surgeons trained in the leading institutes in the US and Europe in developing economies such as that of the Asia Pacific region promotes the in vitro fertilization trends. In addition to reduced treatment costs, combined with quality treatments and noninterventionist laws concerning the IVF treatment, it is also motivating fertility tourism in evolving countries such as India and Thailand.


Restraints


High Cost Of Treatment


The cost of IVF treatment differs due to the absence of reimbursement policies, which may hinder its global progress. Consequently, the astronomical price of assisted reproductive techniques and the absence of insurance coverage for the treatment are restraining this market's growth.


Segment Overview


By Type


The intrauterine insemination (IUI) segment is anticipated to keep on as a highly appealing segment over the next few years. In 2017, the segment accounted for nearly one-third share of the global IVF device market. During the forecast period, the segment is expected to witness a double-digit CAGR.


By Devices


The segments by device such as ovum aspiration pump, imaging systems, micromanipulator, sperm separation system, and cryosystem are assessed to perform uniformly in the course of the forecast period due to their use in fertilization.


By Reagents


The reagents segments are estimated to develop consistently in the course of the forecast period.


By End Users


The fertility clinics segment currently influences the market's largest share and is anticipated to hold its top-posting over 2023. The hospital segment is also projected to become more lucrative in the upcoming years. Throughout the forecast period, the hospital segment is anticipated to surge at a 12.92% CAGR.


Regional Analysis


Asia Pacific To Be Established A Key Frontrunner In Global Market By 2023


The cost of IVF in Asia-Pacific is substantially lesser, especially in India, when likened to industrialized regions. The mounting medical tourism in the region for IVF is also assessed also to supplement the growth of the Asia-Pacific in vitro fertilization IVF market in the region. Due to lenient legal measures and regulatory necessities, India's fertility centers can deliver more patient-oriented therapies when equated with the advanced regions, which is directing the development of the IVF disposables market in the region.


North American Region To Capitalize Access To Innovative Technology


Several progressive nations in Europe and the Americas are documenting a lesser birthrate, which is linked to several socioeconomic influences. As a result, technologies such as IVF have become very popular in these countries. Meanwhile, the developing countries in the North American region, such as Mexico, are also catching up with the trend.


Competitive Landscape


The noteworthy companies profiled in the biologics market report are



  • Cooper Surgical Fertility,

  • Cook Medical,

  • Oxford Gene Technology,

  • Merck KGaA,

  • INVO Bioscience,

  • Thermo Fisher Scientific,

  • Genea Limited,

  • Irvine Scientific,

  • Vitrolife, GENEA BIOMEDIX


The government in Quebec plans to comprise in vitro fertilization to their government-funded health services. The procedure currently costs at least USD 6,000, not counting the expense of the hormones a patient must take. The subsidized treatment will be accessible to heterosexual couples, lesbian couples, as well as to single women.  This development is estimated to signify a pathbreaking development in the infertility treatment devices market.


Recent Developments


Nov 2020 A novel paper in the Journal of the National Cancer Institute, issued by Oxford University Press, shows that taking assisted reproductive technology does not augment the risk women have for getting ovarian cancer. Augmented ovarian cancer risk in ART-treated women associated with the overall population is clarified by nulliparity rather than ART treatment.


Dec 2020 Researchers at Monash University in Australia have revealed that fluid dynamics and acoustic waves can be used to set apart good quality sperm from a semen sample and augment the accomplishment rate of the IVF technique. For the study, the researchers utilized an acoustic field of 19.28 MHz and 1-2 W at a position of 30 degrees in the path of the flow of semen samples.


Dec 2020 Hannah Life has created a one-step solution that raises a couple's probability of natural conception within their own home and a tiny proportion of the price of traditional fertility therapies. Fertility therapies such as intrauterine insemination (IUI) and in-vitro fertilization (IVF) are equally monetarily and emotionally draining to meet the needs of the 25 million women of reproductive age in the US with limited access to treatment.


Dec 2020 Progyny, a fertility-benefits manager, stated first-quarter balances recently that beat expectations but observed that the coronavirus pandemic deeply disrupted its members' access to care. Progyny stated the results as fertility clinics delay procedures owing to the pandemic.


Report Overview


Segmentation Table


By Type



  • Intrauterine Insemination,

  • Intracytoplasmic Sperm Injection,

  • IVF Using Donor Eggs


By Devices



  • Imaging Systems,

  • Sperm Separation System,

  • Ovum Aspiration Pump,

  • Micromanipulator,

  • Cryosystem


By Reagents



  • Embryo Culture Media,

  • Cryopreservation Media,

  • Sperm Processing Media,

  • Ovum Processing Media,


By End-User



  • Fertility Clinics

  • Hospitals

  • Clinical Research Centers


By Region



  • North America

  • Europe

  • Asia Pacific

  • The Middle East & Africa (MEA)

  • Latin America


The MRFR report advances a factual market viewpoint for in vitro fertilization market share on worldwide scale. The report consists of a comprehensive analysis of the growth trends of the global in-vitro fertilization market. The report has thoroughly discussed the key micro and macroeconomic elements influencing the In-Vitro Fertilization (IVF) Industry.

The global in-vitro fertilization (IVF) devices market is projected to witness growth at a CAGR of 10.50% during the forecast period from 2018 to 2023. In-vitro fertilization has become highly popular for its use in the treatment of fertility problems and is often used as the last effort to induce a natural pregnancy. It provides prospective parents the opportunity to have a biological child or can be used to ensure that serious genetic disorders are not passed on to their child. In 2017, the global in-vitro fertilization devices market was valued at USD 6,984.3 Mn, the imminent growth of the market is expected to result in a market value of approximately USD 12,714 Mn by the end of 2023.


Infertility has become a significant issue affecting a considerable portion of the population. The Center for Disease Control & Prevention has found that close to 7.4 Mn women in the US have been recorded as having difficulty conceiving and/or maintaining pregnancy. In the UK the statistics reflect that 1 in 7 couples have trouble conceiving. Several factors have been identified such as low sperm count, inability to form eggs, and several others. IVF techniques have been successfully implemented in such cases to treat infertility; this has increased the demand and use of IVF. Moreover, the increasing demand for infertility treatments has led to increased development of new technologies which offer the highest rate for success. This is particularly significant due to the high cost of IVF treatment.


Although IVF treatments have become adopted widely, the high costs associated with fertility treatments is expected to hamper market growth. In the US, the average cost of one IVF treatment with the exception of required prescription medication is over USD 12,000. Although these figures vary from region to region, they are still fairly expensive and unaffordable. To address this, there is a growing availability of funding and reimbursements for certain in-vitro fertilization treatments which are expected to provide the market with opportunity for growth.


The global in-vitro fertilization devices market is segmented on the basis of product, type, end-user, and region. In-vitro fertilization products are broadly segmented into devices and reagents. Devices are further sub-segmented into imaging systems, sperm separation system, cerosystem, micromanipulator and ovum aspiration pump. Reagents are sub-segmented into cryopreservation media, sperm processing media, ovum processing media, and embryo culture media. Devices account for the most significant share of the market and valued USD 3,739.7 in 2017 due to the increased use of imaging systems in IVF treatments. Moreover, the devices segment is expected to grow at the highest CAGR during the forecast period.


Various types of in-vitro fertilization include intrauterine insemination (IUI), in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and IVF using donor eggs. The IUI segment around for the largest share of the market and is generally preferred as it is minimally invasive and has a good success rate. Meanwhile, the IVF segment is expected to witness the highest growth at a CAGR of 11.68% during the forecast period. End users of IVF methods include fertility clinics, hospitals, clinical research centers, and others. The fertility clinics segment accounts for the largest segment in the market. The hospital segment is the second largest and is expected to grow at the highest CAGR of 12.92%; hospitals have increased service offerings for infertility problems, thus the segments rapid growth.


Regional Analysis


Europe has the most significant share of the global IVF devices market. Government support for research and development activities, the presence of well-established healthcare infrastructure and the high budget for health care expenses are among the key factors driving the growth of the market. European market growth is primarily led by Western Europe countries which include Germany, the UK, and France. The Europe IVF devices market is expected to witness a CAGR of 10.94% during the forecast period.


The Americas IVF devices market account for the second largest regional segment. The region has a high concentration of leading players, and a high adoption rate of advanced technologies which has contributed significantly toward the development of the market. North America leads the Americas IVF devices market. The Asia Pacific is the fastest growing regional market with the highest CAGR during the forecast period. The region has a high demand and requirement for advanced diagnostic methods. The rapidly changing healthcare sector poses huge opportunities for the development of the market.


Meanwhile, the Middle East and Africa has the smallest share of the market which is expected to grow at the lowest CAGR. This is primarily due to the region’s inclusion of the African continent which has a high concentration of under-developed economies with a high requirement for basic healthcare.


Competitive Tracking


The global in-vitro fertilization devices market is fragmented and includes a number of small regional clinics. The report, however, profiles prominent players such as Cook Medical, Cooper Surgical Fertility, Merck KGaA, Thermo Fisher Scientific, INVO Bioscience, Irvine Scientific, GENEA BIOMEDIX, Vitrolife, Oxford Gene Technology, and Genea Limited. These players primarily use product approval, expansion, strategic acquisitions and partnerships as key competitive strategies which influence growth.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 19

3.2 Scope of the Study 19

3.3 Assumptions & Limitations 19

3.3.1 Assumptions 19

3.3.2 Limitations 19

3.4 Market Structure 20

4 Research Methodology

4.1 Research Process 22

4.2 Primary Research 23

4.3 Secondary Research 24

4.4 Market Size Estimation 25

4.5 Forecast Model 25

5 Market Dynamics

5.1 Introduction 27

5.2 Drivers 28

5.2.1 Increased rate of infertility and high demand for IVF techniques 28

5.2.2 Gender selection and growing trend of reproductive tourism 28

5.2.3 Declining fertility rate 28

5.2.4 Technological advancements in infertility treatments 28

5.2.5 Increasing prevalence of obesity 29

5.3 Restraints 29

5.3.1 High procedural costs of assisted reproductive techniques in developed markets 29

5.4 Opportunities 29

5.4.1 Reimbursement for fertility treatments 29

6 Market Factor Analysis

6.1 Value Chain Analysis 31

6.1.1 R&D 31

6.1.2 Manufacturing 31

6.1.3 Distribution 31

6.1.4 Marketing & Sales 31

6.1.5 Post-Sales Monitoring 32

6.2 Porter’s Five Forces Analysis 32

6.2.1 Bargaining Power of Suppliers 32

6.2.2 Bargaining Power of Buyers 33

6.2.3 Threat of New Entrants 33

6.2.4 Threat of Substitutes 33

6.2.5 Intensity of Rivalry 33

7 In-vitro Fertilization Market, by Product

7.1 Overview 35

7.2 Devices 36

7.2.1 Imaging Systems 36

7.2.2 Sperm Separation System 37

7.2.3 Ovum Aspiration Pump 37

7.2.4 Cerosystem 37

7.2.5 Micromanipulator 38

7.3 Reagents 39

7.3.1 Embryo Culture Media 39

7.3.2 Cryopreservation Media 40

7.3.3 Sperm Processing Media 40

7.3.4 Ovum Processing Media 40

8 In-vitro Fertilization Market, by Type

8.1 Overview 42

8.2 Intrauterine Insemination 43

8.3 In-vitro Fertilization 43

8.4 Intracytoplasmic Sperm Injection 44

8.5 IVF Using Donor Eggs 44

9 In-vitro Fertilization Market, by End-User

9.1 Overview 46

9.2 Fertility Clinics 47

9.3 Hospitals 47

9.4 Clinical Research Centers 48

10 Global In-vitro Fertilization Market, By Region

10.1 Overview 50

10.2 Europe 51

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1 Western Europe 53

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1.1 Germany 56

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1.2 France 58

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1.3 UK 60

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1.4 Italy 62

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1.5 Spain 64

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.1.6 Rest of Western Europe 66

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.2.2 Eastern Europe 68

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.3 Americas 70

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.3.1 North America 72

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.3.1.1 US 75

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.3.1.2 Canada 77

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.3.2 South America 79

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4 Asia Pacific 81

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4.1 Japan 83

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4.2 China 85

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4.3 India 87

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4.4 Australia 89

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4.5 Republic of Korea 91

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.4.6 Rest of Asia Pacific 93

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.5 Middle East & Africa 95

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.5.1 Middle East 97

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

10.5.2 Africa 99

In-vitro Fertilization Market, by Product

In-vitro Fertilization Market, by Type

In-vitro Fertilization Market, by End-User

11 Competitive Landscape

11.1 Introduction 102

11.2 Company Share Analysis 102

11.2.1 Key Strategic Analysis 103

12 Company Profiles

12.1 Cook Medical 105

12.1.1 Company Overview 105

12.1.2 Financial Overview 105

12.1.3 Products/Services Offering 105

12.1.4 Key Developments 105

12.1.5 SWOT Analysis 105

12.1.6 Key Strategy 106

12.2 Cooper Surgical Fertility 107

12.2.1 Company Overview 107

12.2.2 Financial Overview 107

12.2.3 Products/Services Offering 108

12.2.4 Key Developments 108

12.2.5 SWOT Analysis 108

12.2.6 Key Strategy 108

12.3 Merck KGaA 109

12.3.1 Company Overview 109

12.3.2 Financial Overview 109

12.3.3 Products/Services Offering 110

12.3.4 Key Developments 110

12.3.5 SWOT Analysis 110

12.3.6 Key Strategy 110

12.4 Thermo Fisher Scientific 111

12.4.1 Company Overview 111

12.4.2 Financial Overview 111

12.4.3 Products/Services Offering 112

12.4.4 Key Developments 112

12.4.5 SWOT Analysis 112

12.4.6 Key Strategy 112

12.5 INVO Bioscience 113

12.5.1 Company Overview 113

12.5.2 Financial Overview 113

12.5.3 Products/Services Offering 114

12.5.4 Key Developments 114

12.5.5 SWOT Analysis 114

12.5.6 Key Strategy 114

12.6 Irvine Scientific 115

12.6.1 Company Overview 115

12.6.2 Financial Overview 115

12.6.3 Products/Services Offering 115

12.6.4 Key Developments 116

12.6.5 SWOT Analysis 116

12.6.6 Key Strategy 116

12.7 GENEA BIOMEDX 117

12.7.1 Company Overview 117

12.7.2 Financial Overview 117

12.7.3 Products/Services Offering 117

12.7.4 Key Developments 117

12.7.5 SWOT Analysis 118

12.7.6 Key Strategy 118

12.8 Vitrolife 119

12.8.1 Company Overview 119

12.8.2 Financial Overview 119

12.8.3 Products/Services Offering 120

12.8.4 Key Developments 120

12.8.5 SWOT Analysis 120

12.8.6 Key Strategy 120

12.9 Oxford Gene Technology 121

12.9.1 Company Overview 121

12.9.2 Financial Overview 121

12.9.3 Products/Services Offering 121

12.9.4 Key Developments 121

12.9.5 SWOT Analysis 121

12.9.6 Key Strategy 122

12.10 Genea Limited 123

12.10.1 Company Overview 123

12.10.2 Financial Overview 123

12.10.3 Products/Services Offering 123

12.10.4 Key Developments 123

12.10.5 SWOT Analysis 124

12.10.6 Key Strategy 124

13 Appendix

13.1 Discussion Blue Print 126

14 List of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 PRIMARY INTERVIEWS 22

TABLE 3 GLOBAL IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 35

TABLE 4 GLOBAL IN-VITRO FERTILIZATION MARKET FOR DEVICES BY REGION, 2020 TO 2027 (USD MILLION) 36

TABLE 5 GLOBAL IN-VITRO FERTILIZATION MARKET FOR IMAGING SYSTEM BY REGION, 2020 TO 2027 (USD MILLION) 36

TABLE 6 GLOBAL IN-VITRO FERTILIZATION MARKET FOR SPERM SEPARATION SYSTEM BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 7 GLOBAL IN-VITRO FERTILIZATION MARKET FOR OVUM ASPIRATION PUMP BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 8 GLOBAL IN-VITRO FERTILIZATION MARKET FOR CEROSYSTEM BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 9 GLOBAL IN-VITRO FERTILIZATION MARKET FOR MICROMANIPULATOR BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 10 GLOBAL IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 11 GLOBAL IN-VITRO FERTILIZATION MARKET FOR EMBRYO CULTURE MEDIA BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 12 GLOBAL IN-VITRO FERTILIZATION MARKET FOR CRYOPRESERVATION MEDIA BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 13 GLOBAL IN-VITRO FERTILIZATION MARKET FOR SPERM PROCESSING MEDIA BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 14 GLOBAL IN-VITRO FERTILIZATION MARKET FOR OVUM PROCESSING MEDIA BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 15 GLOBAL IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 42

TABLE 16 GLOBAL IN-VITRO FERTILIZATION MARKET FOR INTRAUTERINE INSEMINATION (IUI) BY REGION,

2020 TO 2027 (USD MILLION) 43

TABLE 17 GLOBAL IN-VITRO FERTILIZATION MARKET FOR IN VITRO FERTILIZATION (IVF) BY REGION, 2020 TO 2027 (USD MILLION) 43

TABLE 18 GLOBAL IN-VITRO FERTILIZATION MARKET FOR INTRACYTOPLASMIC SPERM INJECTION (ICSI) BY REGION,

2020 TO 2027 (USD MILLION) 44

TABLE 19 GLOBAL IN-VITRO FERTILIZATION MARKET FOR IVF USING DONOR EGGS BY REGION, 2020 TO 2027 (USD MILLION) 44

TABLE 20 GLOBAL IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 46

TABLE 21 GLOBAL IN-VITRO FERTILIZATION MARKET FOR FERTILITY CLINICS BY REGION, 2020 TO 2027 (USD MILLION) 47

TABLE 22 GLOBAL IN-VITRO FERTILIZATION MARKET FOR HOSPITALS BY REGION, 2020 TO 2027 (USD MILLION) 47

TABLE 23 GLOBAL IN-VITRO FERTILIZATION MARKET FOR CLINICAL RESEARCH CENTERS BY REGION, 2020 TO 2027 (USD MILLION) 48

TABLE 24 GLOBAL IN-VITRO FERTILIZATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 50

TABLE 25 EUROPE IN-VITRO FERTILIZATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 51

TABLE 26 EUROPE IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 51

TABLE 27 EUROPE IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 52

TABLE 28 EUROPE IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 52

TABLE 29 EUROPE IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 52

TABLE 30 EUROPE IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 53

TABLE 31 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 53

TABLE 32 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 54

TABLE 33 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 54

TABLE 34 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 54

TABLE 35 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 55

TABLE 36 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 55

TABLE 37 GERMANY IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 56

TABLE 38 GERMANY IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 39 GERMANY IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 40 GERMANY IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 41 GERMANY IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 57

TABLE 42 FRANCE IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 58

TABLE 43 FRANCE IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 44 FRANCE IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 45 FRANCE IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 59

TABLE 46 FRANCE IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 59

TABLE 47 UK IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 60

TABLE 48 UK IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 60

TABLE 49 UK IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 60

TABLE 50 UK IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 51 UK IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 61

TABLE 52 ITALY IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 62

TABLE 53 ITALY IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 54 ITALY IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 55 ITALY IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 63

TABLE 56 ITALY IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 63

TABLE 57 SPAIN IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 64

TABLE 58 SPAIN IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 59 SPAIN IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 60 SPAIN IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 61 SPAIN IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 65

TABLE 62 REST OF WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 66

TABLE 63 REST OF WESTERN EUROPE IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 64 REST OF WESTERN EUROPE IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 65 REST OF WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 66 REST OF WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 67

TABLE 67 EASTERN EUROPE IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 68

TABLE 68 EASTERN EUROPE IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 69 EASTERN EUROPE IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 70 EASTERN EUROPE IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 71 EASTERN EUROPE IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 69

TABLE 72 AMERICAS IN-VITRO FERTILIZATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 70

TABLE 73 AMERICAS IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 70

TABLE 74 AMERICAS IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 75 AMERICAS IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 76 AMERICAS IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 77 AMERICAS IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 72

TABLE 78 NORTH AMERICA IN-VITRO FERTILIZATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 72

TABLE 79 NORTH AMERICA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 73

TABLE 80 NORTH AMERICA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 81 NORTH AMERICA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 82 NORTH AMERICA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 74

TABLE 83 NORTH AMERICA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 74

TABLE 84 US IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 75

TABLE 85 US IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 75

TABLE 86 US IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 75

TABLE 87 US IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 88 US IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 76

TABLE 89 CANADA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 77

TABLE 90 CANADA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 77

TABLE 91 CANADA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 77

TABLE 92 CANADA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 93 CANADA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 78

TABLE 94 SOUTH AMERICA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 79

TABLE 95 SOUTH AMERICA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 96 SOUTH AMERICA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 97 SOUTH AMERICA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 98 SOUTH AMERICA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 80

TABLE 99 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 81

TABLE 100 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 81

TABLE 101 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 102 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 103 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 104 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 83

TABLE 105 JAPAN IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 83

TABLE 106 JAPAN IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 107 JAPAN IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 108 JAPAN IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 109 JAPAN IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 84

TABLE 110 CHINA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 85

TABLE 111 CHINA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 112 CHINA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 113 CHINA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 114 CHINA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 86

TABLE 115 INDIA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 87

TABLE 116 INDIA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 117 INDIA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 118 INDIA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 119 INDIA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 88

TABLE 120 AUSTRALIA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 89

TABLE 121 AUSTRALIA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 89

TABLE 122 AUSTRALIA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 89

TABLE 123 AUSTRALIA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 90

TABLE 124 AUSTRALIA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 90

TABLE 125 REPUBLIC OF KOREA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 91

TABLE 126 REPUBLIC OF KOREA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 127 REPUBLIC OF KOREA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 128 REPUBLIC OF KOREA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 92

TABLE 129 REPUBLIC OF KOREA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 92

TABLE 130 REST OF ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 93

TABLE 131 REST OF ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 132 REST OF ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 133 REST OF ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 94

TABLE 134 REST OF ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 94

TABLE 135 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 95

TABLE 136 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 95

TABLE 137 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 96

TABLE 138 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 96

TABLE 139 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 96

TABLE 140 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 97

TABLE 141 MIDDLE EAST IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 97

TABLE 142 MIDDLE EAST IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 97

TABLE 143 MIDDLE EAST IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 98

TABLE 144 MIDDLE EAST IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 98

TABLE 145 MIDDLE EAST IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 98

TABLE 146 AFRICA IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 99

TABLE 147 AFRICA IN-VITRO FERTILIZATION MARKET FOR DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 99

TABLE 148 AFRICA IN-VITRO FERTILIZATION MARKET FOR REAGENTS BY TYPE, 2020 TO 2027 (USD MILLION) 99

TABLE 149 AFRICA IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 100

TABLE 150 AFRICA IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 100


15 List of Figures

FIGURE 1 GLOBAL IN-VITRO FERTILIZATION MARKET: MARKET STRUCTURE 20

FIGURE 2 RESEARCH PROCESS 22

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 25

FIGURE 4 MARKET DYNAMICS ANALYSIS OF THE GLOBAL IN-VITRO FERTILIZATION MARKET 27

FIGURE 5 VALUE CHAIN: GLOBAL IN-VITRO FERTILIZATION MARKET 31

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL IN-VITRO FERTILIZATION MARKET 32

FIGURE 7 GLOBAL IN-VITRO FERTILIZATION MARKET BY PRODUCT, 2020 & 2027 (USD MILLION) 35

FIGURE 8 GLOBAL IN-VITRO FERTILIZATION MARKET BY TYPE, 2020 & 2027 (USD MILLION) 42

FIGURE 9 GLOBAL IN-VITRO FERTILIZATION MARKET BY END-USER, 2020 & 2027 (USD MILLION) 46

FIGURE 10 GLOBAL IN-VITRO FERTILIZATION MARKET BY REGION, 2020 & 2027 (USD MILLION) 50

FIGURE 11 EUROPE IN-VITRO FERTILIZATION MARKET SHARE BY REGION, 2020 (%) 51

FIGURE 12 WESTERN EUROPE IN-VITRO FERTILIZATION MARKET BY COUNTRY, 2020 (%) 53

FIGURE 13 AMERICAS IN-VITRO FERTILIZATION MARKET SHARE BY REGION, 2020 (%) 70

FIGURE 14 NORTH AMERICA IN-VITRO FERTILIZATION MARKET SHARE BY COUNTRY, 2020 (%) 72

FIGURE 15 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET SHARE BY REGION, 2020 (%) 81

FIGURE 16 MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SHARE BY REGION, 2020 (%) 95

FIGURE 17 GLOBAL IN-VITRO FERTILIZATION MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 102

In Vitro Fertilization Market

Global In-vitro Fertilization Market: Competitive Landscape


The prominent players in the global in-vitro fertilization market are Cook Medical, Irvine Scientific Sales Company, Inc., Cooper Surgical, Merck KGaA, and others.


Cooper Surgical Fertility (Origio) accounted for the largest market share of the global in-vitro fertilization market, with around 25.4% of the market share in 2017. The large share of the company is attributed to innovative products that address a wide range of patients with infertility. Moreover, Cooper Surgical Fertility is focusing on bringing health and wellness to individuals and communities worldwide. A Cooper Surgical Fertility Company is committed to advancing the health of families with its diversified portfolio of products and services to mainly focus on women health, fertility, and diagnostic products. It targets specific difficult-to-cure diseases with the help of its core R&D expertise.


Vitrolife accounts for approximately 21.7% share in the in-vitro fertilization market owing to a wide range of product portfolio. Vitrolife provides a high quality of IVF laboratories product in the market. The company has production facilities in more than ten countries globally.


Cook Medical holds the third largest position in the global in-vitro fertilization market with a 16.2% market share. Irvine Scientific holds the fourth largest position in the global in-vitro fertilization market with a market share of 10.5%. Cook Medical is the spin-off of Abbott Laboratories and was formed in 2013 and therefore has more than 100 years of legacy. Abbott Laboratories company operates through four reportable segments, namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Furthermore, the company has two non-reportable segments, namely, diabetes care and medical optics. Cook Medical is a highly focused research-driven biopharmaceutical company. It targets specific difficult-to-cure diseases with the help of its core R&D expertise.


Irvin Scientific is focusing on innovation and development of cell culture media, reagents, and medical devices for researchers. Irvin Scientific provides unrivaled services and products to scientists working on cell therapy, assisted reproductive technology, and industrial cell culture to produce biopharmaceuticals and vaccines. It targets specific difficulties to cure diseases with the help of its core R&D expertise. Irvin Scientific has remained focused on media while becoming a global leader in media products and services.


Thermo Fisher Scientific Inc. specializes in various biotechnology products such as analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others. Ortho Clinical Diagnostics (Part of Johnson & Johnson Services Inc.) is serving the global clinical laboratory and immunohematology communities across hospitals, hospital networks, blood banks, and labs in more than 120 countries. The company specializes in in-vitro diagnostics, clinical labs, transfusion medicine, and immunohematology.


Merck KGaA is focusing on bringing health and wellness to individuals’ communities worldwide.  Merck KGaA is committed to advancing the health of families with its diversified portfolio of products and services to mainly focus on women health, fertility, and diagnostic products. Merck KGaA is a leading pharmaceutical company which has a varied range of products sub-segmented into healthcare, life science, and performance material.